Highland Capital Management (Texas)’s Vertex Pharmaceuticals VRTX Stock Holding History

Highland Capital Management (Texas)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,000	Closed	-$1.1M	–	372
2019 Q1	$1.1M	Sell	6,000 -4,000	-40%	-$739K	0.07%	199
2018 Q4	$1.66M	Buy	10,000 +4,000	+67%	+$693K	0.13%	123
2018 Q3	$1.16M	Sell	6,000 -6,000	-50%	-$1.07M	0.06%	166
2018 Q2	$2.04M	Sell	12,000 -9,500	-44%	-$1.47M	0.12%	127
2018 Q1	$3.5M	Buy	21,500 +20,000	+1,333%	+$3.27M	0.18%	110
2017 Q4	$225K	Buy	+1,500	New	+$222K	0.01%	282
2017 Q3	–	Sell	-18,000	Closed	-$2.32M	–	344
2017 Q2	$2.32M	Buy	+18,000	New	+$2.17M	0.1%	136
2014 Q3	–	Sell	-38,255	Closed	-$3.62M	–	275
2014 Q2	$3.62M	Buy	+38,255	New	+$2.68M	0.13%	111
2014 Q1	–	Sell	-10,500	Closed	-$780K	–	245
2013 Q4	$780K	Buy	+10,500	New	+$731K	0.04%	126

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Highland Capital Management (Texas)'s VRTX Position: Q2 2019 in Review

Highland Capital Management (Texas) sold out of Vertex Pharmaceuticals (VRTX) in Q2 2019, closing a stake of 6,000 shares — an estimated $1.1M sold.

Highland Capital Management (Texas) first reported a position in VRTX in Q4 2013 and held it in 9 quarters. The position peaked at $3.62M in Q2 2014. 716 funds tracked by Wall St. Rank hold VRTX as of Q2 2019.

Highland Capital Management (Texas) reported no remaining Vertex Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Highland Capital Management (Texas) sold 6,000 Vertex Pharmaceuticals shares in Q2 2019, an estimated $1.1M.
Highland Capital Management (Texas) first reported a position in Vertex Pharmaceuticals in Q4 2013 and held it in 9 quarters.
Highland Capital Management (Texas)'s Vertex Pharmaceuticals position peaked at $3.62M in Q2 2014.
716 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.